Status:
UNKNOWN
MBCT and CBT for Chronic Pain in Multiple Sclerosis
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Multiple Sclerosis Society
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic pain is one of the most prevalent, disabling and persistent symptoms affecting people with multiple sclerosis (MS). Different nonpharmacological treatments are known to be beneficial for manag...
Detailed Description
Chronic pain is one of the most prevalent, disabling, and persistent symptoms associated with multiple sclerosis (MS). Approximately 50 - 60% of adults with multiple sclerosis experience moderate or s...
Eligibility Criteria
Inclusion
- Inclusion criteria are:
- 18 years of age or older;
- a diagnosis of clinically definite MS confirmed by participant's provider;
- the presence of chronic pain, defined as average pain intensity in the past week of at least moderate severity (defined as a ≥3 on the 0-10 numerical rating scale) and pain of at least three months duration, with pain reportedly present \> half the days in the past three months;
- reads and speaks English;
- has access and is able to communicate over the telephone; and
- has a computer or digital device with video capabilities (any operating system) and internet access.
- Exclusion criteria are:
- severe cognitive impairment;
- currently in psychotherapy for pain \> once a month; and
- previously participated in a pain study that used CBT or MBCT.
Exclusion
Key Trial Info
Start Date :
November 28 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2022
Estimated Enrollment :
273 Patients enrolled
Trial Details
Trial ID
NCT03782246
Start Date
November 28 2018
End Date
August 1 2022
Last Update
April 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UW Medicine Multiple Sclerosis Center
Seattle, Washington, United States, 98195